Design of Cyclic Peptides - Peptide and Protein Design for Biopharmaceutical Applications - page 167

[38] R. H.Kimura, A. T. Tran and J. A. Camarero, Biosynthesis of the cyclotide Kalata B1
by using protein splicing, Angewandte Chemie - International Edition , 45, 973-976
(2006).
[39] I. Rubio-Aliaga and H. Daniel, Mammalian peptide transporters as targets for drug
delivery, Trends in Pharmacological Sciences , 23, 434-440 (2002).
[40] N. J. P. Dubree et al ., Selective alpha 4 beta 7 integrin antagonists and their
potential as antiinflammatory agents, Journal of Medicinal Chemistry , 45,
3451-3457 (2002).
[41] R. H. Li, R. H. Hoess, J. S. Bennett andW. F. DeGrado, Use of phage display to probe
the evolution of binding specificity and affinity in integrins, Protein Engineering , 16,
65-72 (2003).
[42] C. Gilon, C. Mang, E. Lohof, A. Friedler and H. Kessler, In: M. Goodman, A. Felix,
L. Moroder and C. Toniolo, Houben-Weyl: Methods of Organic Chemistry , Thieme
Verlag, Stuttgart, 2003, 461-542.
[43] C. Gilon, D. Halle, M. Chorev, Z. Selinger and G. Byk, Backbone cyclization - A new
method for conferring conformational constraint on peptides, Biopolymers , 31, 745-
750 (1991).
[44] R. C. D. Milton, S. C. F. Milton and S. B. H. Kent, Total chemical synthesis of a D -
enzyme - The enantiomers of HIV-1 protease show demonstration of reciprocal
chiral substrate-specificity, Science , 256, 1445-1448 (1992).
[45] M. Chorev and M. Goodman, Recent developments in retro peptides and proteins -
An ongoing topochemical exploration, Trends in Biotechnology , 13, 438-445
(1995).
[46] S. Lande, Retrobradykinin - peptide with reverse sequence of bradykinin, Journal of
Organic Chemistry , 27, 4558-4562 (1962).
[47] J. Rudinger, In: E.J. Ari¨ns, Drug Design , Academic Press, 1971, 319-649.
[48] H. Gerlach, J. A. Owtschinnikow and V. Prelog, Cycloenantiomerie þ cyclodias-
tereomerie. 2. Mitteilung uber cycloenantiomere cyclo-hexaalanyle þ ein cycloe-
nantiomeres cyclo-diglycyl-tetraalanyl, Helvetica Chimica Acta , 47, 2294-2301
(1964).
[49] H. Gerlach, G. Haas and V. Prelog, Uber zwei cycloisomere triglycyl-Tri-L-alanyle,
Helvetica Chimica Acta , 49, 603-607 (1966).
[50] V. Prelog and H. Gerlach, Cycloenantiomerie and cyclodiastereomerie. 1.
Mitteilung, Helvetica Chimica Acta , 47, 2288-2294 (1964).
[51] M. M. Shemyakin, Y. A. Ovchinnikov and V. T. Ivanov, Topochemical investiga-
tions on peptide systems, Angewandte Chemie - International Edition , 8, 492-499
(1969).
[52] H. Kessler et al ., Alanine containing analogs of cyclo(- D -Pro-Phe-Thr-Lys(Z)-Trp-
Phe-) - Conformationally controlled structure-activity-relationships, Tetrahedron ,
44, 745-759 (1988).
[53] D. Heckmann et al ., Probing integrin selectivity: Rational design of highly active and
selective ligands for the alpha 5 beta 1 and alpha v beta 3 integrin receptor,
Angewandte Chemie - International Edition , 46, 3571-3574 (2007).
[54] D. Ron et al ., N-methylated analogs of Ac[Nle28,31]Cck(26-33) - Synthesis, activ-
ity, and receptor selectivity, Journal of Medicinal Chemistry , 35, 2806-2811 (1992).
[55] C. Gilon, M. A. Dechantsreiter, F. Burkhart, A. Friedler and H. Kessler,
In: M. Goodmann, A. Felix, L. Moroder and C. Toniolo, Houben-Weyl: Methods
of Organic Chemistry , Thieme Verlag, Stuttgart, New York, 2003, 215-271.